Nosocomial Infections and Cases of Sphingomonas Paucimobilis

Year 2019, Volume: 20 Issue: 2, 164 - 170, 31.08.2019

Fatma Sırmatel , Elham Behzadi Oğuz Karabay , Aynur Özensoy

https://doi.org/10.4274/meandros.galenos.2016.2341

Cited By: 2

Abstract

Sphingomonas paucimobilis (S. paucimobilis), especially in patients with immune suppressive and very rare in healthy people, attracted attention recently, causing nosocomial infections, is a gram-negative, aerobic bacillus. This bacterial nosocomial infection in our hospital as a first six-month period, six times was isolated from five patients. These five patients were acute peritonitis, vaginal cuff, surgical field, soft tissue and bloodstream infection. The identification of microbiological methods known to S. paucimobilis was examined by the antibiotic sensitivity disk diffusion test. Antibiotic sensitivity of the isolated bacteria were the same. From the environment and environment cultures S. paucimobilis was isolated once from the use water as a hospital infection effect. It was realized that the chlorination of hospital waters was inadequate during that period. Our hospital was thought to have a small epidemic. In conclusion, S. paucimobilis has recently been investigated in the context of literature with the belief that a new nosocomial infection will be affected.

Keywords

S. paucimobilis , immunosuppressive patients , nosocomial infections

References

• 1. Perl TM. Surveillance, reporting, and the use of computers. In: Wenzel RP, ed. *Prevention and Control of Nosocomial Infections*. Second edition, Williams & Wilkins, Baltimore, Maryland, 1993, p.139-76.
• 2. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections. 1988. *Am J Infect Control* 1988; 16: 128-40.
• 3. Ryan MP, Adley CC. *Sphingomonas paucimobilis*: a persistent Gram-negative nosocomial infectious organism. *J Hosp Infect* 2010; 75: 153-57.
• 4. Lin JN, Lai CH, Chen YH, et al. *Sphingomonas paucimobilis* bacteremia in humans: 16 case reports and a literature review. *J Microbiol Immunol Infect* 2010; 43: 35-42.
• 5. Maragakis L, Chalwarith R, Srivinivasan A, Torriani F, et al. *Sphingomonas paucimobilis* bloodstream infections associated with contaminated intravenous fentanyl. *Emerg Infect Dis* 2009; 1: 12-18.
• 6. Dervisoglu E, Meric M, Kalender B, Sengul E. *Sphingomonas paucimobilis* peritonitis: a case report and literature review. *Perit Dial Int* 2008; 8: 547-50.
• 7. Casadewall A, Freundlich LF, Profiski L. Septic shock caused by *Pseudomonas paucimobilis*. *Clin Infect Dis* 1992; 14: 784.
• 8. Tambawala AQ, Hamid S, Khan I, Ali A. Continuous ambulatory peritoneal dialysis (CAPD) associated in a child: a rare case of peritonitis caused by *Sphingomonas paucimobilis*. *J Pak Med Assoc* 2011; 6: 178-80.
• 9. Willke A, Kolayli F, Yavuz S, Vahaboglu H. Water-borne *Sphingomonas paucimobilis* epidemic in an intensive care unit. *J Infect* 2009; 58: 253-55.
• 10. Bulut C, Yetkin MA, Koruk ST, Erdinç FS, Karakoç EA. A rare cause of nosocomial bacteremia: *Sphingomonas paucimobilis*. *Mikrobiyol Bul* 2008; 42: 685-88.
• 11. Cheong HS, Wi YM, Moon SY, Kang CI, Son JS, Ko KS, Chung DR, Lee NY, Song JH, Peck KR. Clinical features and treatment outcomes of infections caused by *Sphingomonas paucimobilis*. *Infect Control Hosp Epidemiol* 2008; 29: 990-92.
• 12. Toh HS, Tay HT, Kuar WK, Weng TC, Tang HJ, Tan CK. Risk factors associated with *Sphingomonas paucimobilis* infection. *J Microbiol Immunol Infect* 2011; 44: 2890-95.
• 13. Kilic A, Senses Z, Kurekci AE, Aydogan H, Sener K, Kismet E, Basustaoglu AC. Nosocomial outbreak of *Sphingomonas paucimobilis* bacteremia in a hemato/oncology unit. *Jpn J Infect Dis* 2007; 60: 394-96.
• 14. Ensminger SA, Wright RS, Baddour LM, Afessa B. Suspected ventilator-associated pneumonia in cardiac patients admitted to the coronary care unit. *Mayo Clin Proc* 2006; 81: 32-5.
• 15. Källman O, Lundberg C, Wretlind B, Ortqvist A. Rare bacteria species found in wounds of tsunami patients. Predominance of gram-negative rods, increased antibiotic resistance. *Lakartidningen* 2005; 102: 3660-65.
• 16. Perola O, Nousiainen T, Suomalainen S, Aukee S, Kärkkäinen UM, Kauppinen J, Ojanen T, Katila ML. Recurrent *Sphingomonas paucimobilis* bacteraemia associated with a multi-bacterial water-borne epidemic among neutropenic patients. *J Hosp Infect* 2002; 50: 196-201.
• 17. Hsueh PR, Teng LJ, Yang PC, Chen YC, Pan HJ, Ho SW, Luh KT. Nosocomial infections caused by *Sphingomonas paucimobilis*: clinical features and microbiological characteristics. *Clin Infect Dis* 1998; 26: 676-81.
• 18. Nandy S, Dudeja M, Das AK, Tiwari R. Community Acquired Bacteremia by *Sphingomonas paucimobilis*: Two Rare Case Reports. *J Clin Diagn Res* 2013; 7: 2947-79.
• 19. Glupczynski Y, Hansen W, Dratwa M, Tielemans C, Wens R, Collart F, Yourassowsky E. *Pseudomonas paucimobilis* peritonitis in patients treated by peritoneal dialysis. *J Clin Microbiol* 1984; 20: 1225-26.
• 20. Turhanoğlu NM, Bilman FB. Sekiz yıllık dönemde *Sphingomonas paucimobilis* infeksiyonları. *Flora* 2013; 16: 113-118.
• 21. Bayram N, Devrim İ, Apa H, Gulfidan G, Turkyılmaz HN, Gunay İ. *Sphingomonas paucimobilis* infections in children: 24 case reports. *Mediterr J Hematol Infect Dis* 2013; 5: e2013040.
• 22. Kıvrak EE, Taşbakan MI, Öztürk AM, ve ark. Nadir bir cerrahi alan infeksiyonu etkeni: *Sphingomonas paucimobilis* (olgu sunumu). *ANKEM Derg* 2010; 24: 234-36.